Shanta Bantia
individual
About
Shanta Bantia, PhD, is a biotech scientist-executive focused on purine nucleoside phosphorylase biology, oncology, metabolic disease, and antiviral therapeutics. She has served as founder and CEO of Nitor Therapeutics, CSO of Laevoroc Immunology, and co-founder, CSO, and board member of MetaShape Pharma. Earlier, she spent roughly two decades at BioCryst Pharmaceuticals, where public biographies credit her with advancing compounds including RAPIVAB, MUNDESINE, and Galidesivir-related programs.
Areas of interest
oncologycancer immunotherapyimmunologymetabolic diseaseobesitycardiometabolic healthlongevityinfectious diseaseantiviral therapeuticsdrug discoveryearly clinical developmentPNP biologySTING biologyNAD+ metabolism